IN2009CN02681A - - Google Patents

Info

Publication number
IN2009CN02681A
IN2009CN02681A IN2681CHN2009A IN2009CN02681A IN 2009CN02681 A IN2009CN02681 A IN 2009CN02681A IN 2681CHN2009 A IN2681CHN2009 A IN 2681CHN2009A IN 2009CN02681 A IN2009CN02681 A IN 2009CN02681A
Authority
IN
India
Prior art keywords
ethyl
methyl
protecting groups
carboxyl protecting
hydrophilic moieties
Prior art date
Application number
Other languages
English (en)
Inventor
Sebastian Knor
Armin Modlinger
Hans Jurgen Wester
Horst Kessler
Original Assignee
Univ Muenchen Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Muenchen Tech filed Critical Univ Muenchen Tech
Publication of IN2009CN02681A publication Critical patent/IN2009CN02681A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN2681CHN2009 2006-12-08 2007-10-10 IN2009CN02681A (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0624587.2A GB0624587D0 (en) 2006-12-08 2006-12-08 Chelating agent
PCT/GB2007/004733 WO2008068516A1 (en) 2006-12-08 2007-12-10 Chelating agent

Publications (1)

Publication Number Publication Date
IN2009CN02681A true IN2009CN02681A (https=) 2015-08-07

Family

ID=37711827

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2681CHN2009 IN2009CN02681A (https=) 2006-12-08 2007-10-10

Country Status (8)

Country Link
US (1) US20100081799A1 (https=)
EP (1) EP2099776B1 (https=)
JP (2) JP5705434B2 (https=)
CN (1) CN101605768A (https=)
CA (1) CA2671788A1 (https=)
GB (1) GB0624587D0 (https=)
IN (1) IN2009CN02681A (https=)
WO (1) WO2008068516A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0624587D0 (en) * 2006-12-08 2007-01-17 Univ Muenchen Tech Chelating agent
CN102898392B (zh) * 2012-09-06 2015-08-12 中国工程物理研究院核物理与化学研究所 N-乙酰氧苄基-3-[-三叔丁氧甲酰基-四氮杂环十二烷基]中间体及其制备方法
CN104230832B (zh) * 2014-08-25 2018-07-27 曲靖师范学院 一种4,4’,4”,4”’-(1,4,7,10-四氮杂环十二烷-1,4,7,10-四基)四亚甲基四苯甲醛的合成方法
CN104307495A (zh) * 2014-10-14 2015-01-28 常州大学 一种含有四氮杂环的新型螯合树脂及其制备方法
IL269763B2 (en) * 2017-03-30 2024-08-01 Univ Cornell Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
WO2018204872A2 (en) 2017-05-05 2018-11-08 Fusion Pharmaceuticals Inc. Igf-1r monoclonal antibodies and uses thereof
MA48861A (fr) 2017-05-05 2020-04-01 Fusion Pharmaceuticals Inc Améliorations pharmacocinétiques de chélates bifonctionnels et leurs utilisations
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
KR102152939B1 (ko) * 2019-04-30 2020-09-07 한국화학연구원 공유결합성 트리아졸로 연결된 가시광선 흡수 광촉매, 이의 제조방법 및 이를 이용한 아자이드-알카인 고리화 첨가반응으로 트리아졸 유도체를 제조하는 방법
KR20230173150A (ko) 2021-04-20 2023-12-26 테라파워, 엘엘씨 Ac-225 생성용 티타니아 기반 발생기

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341373C (en) * 1988-06-24 2002-07-02 Roberta C. Cheng Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
ZA894792B (en) * 1988-06-24 1991-04-24 Dow Chemical Co Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
NZ542371A (en) * 2003-03-19 2008-10-31 Universitatsspital Basel Radiolabeled conjugates based on substance P and the uses thereof
WO2005001415A2 (en) * 2003-05-23 2005-01-06 Epix Pharmaceuticals, Inc. Optically pure and enriched isomers of chelating ligands and contrast agents
WO2006110745A2 (en) * 2005-04-08 2006-10-19 Cytogen Corporation Conjugated anti-psma antibodies
GB0624587D0 (en) * 2006-12-08 2007-01-17 Univ Muenchen Tech Chelating agent

Also Published As

Publication number Publication date
CN101605768A (zh) 2009-12-16
GB0624587D0 (en) 2007-01-17
EP2099776A1 (en) 2009-09-16
JP5705434B2 (ja) 2015-04-22
CA2671788A1 (en) 2008-06-12
JP2015155407A (ja) 2015-08-27
JP2010511687A (ja) 2010-04-15
US20100081799A1 (en) 2010-04-01
WO2008068516A1 (en) 2008-06-12
EP2099776B1 (en) 2015-10-07

Similar Documents

Publication Publication Date Title
IN2009CN02681A (https=)
MX2013002558A (es) Derivado de imidazol de heteroanillo fusionado que tiene efecto de activacion de proteina cinasa activada por monofosfato de adenosina (amk).
MX2009011783A (es) Inhibidores de iap.
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
MX2010012199A (es) Compuesto de cromeno.
EP2090570A4 (en) IMIDAZOLE DERIVATIVE
WO2005105732A8 (en) Substituted methyl aryl or heteroaryl amide compounds
MY148703A (en) Polycyclic cinnamide derivatives
IL204621A (en) Amino Acid Derivatives - γ - In bicycles preparations containing them and their uses
MY146613A (en) Catalyst for curing epoxides
AU2008235089A8 (en) Insecticidal aryl isoxazoline derivatives
MX2012000441A (es) Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer.
MY149180A (en) Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
MX2009003927A (es) Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes.
MX2008013728A (es) Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo.
WO2009081152A3 (en) Antimicrobial compounds
WO2008117796A1 (ja) 新規ムチリン誘導体
WO2008136512A1 (ja) 光学異性体用分離剤
ATE500212T1 (de) Bisphenol monoester
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
WO2008152011A9 (de) Katalysator für die härtung von epoxiden
WO2006082151A3 (en) Synergistic mixtures of c6- to c12-alkanediols and tropolone (derivatives)
MX2010001566A (es) Derivado de aminopirazolamida.
MY158069A (en) Tricyclic compound and pharmaceutical use thereof